- Home
- ACVA vs VKTX Comparison
ACVA vs VKTX Comparison
Compare ACVA & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACVA | VKTX |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 3.8B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ACVA | VKTX |
|---|---|---|
| Price | $8.01 | $37.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | $13.96 | ★ $87.07 |
| AVG Volume (30 Days) | ★ 3.1M | 2.9M |
| Earning Date | 11-05-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $735,475,000.00 | N/A |
| Revenue This Year | $21.22 | N/A |
| Revenue Next Year | $11.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.40 | N/A |
| 52 Week Low | $4.95 | $18.92 |
| 52 Week High | $22.47 | $49.67 |
Technical Indicators
Market Signals| Indicator | ACVA | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 53.21 |
| Support Level | $8.00 | $36.49 |
| Resistance Level | $8.37 | $39.99 |
| Average True Range (ATR) | 0.33 | 1.88 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 80.77 | 57.05 |
Price Performance
Historical ComparisonAbout ACVA ACV Auctions Inc.
ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.